The life and death of platelets

In the Media
 
At the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress in Berlin, Germany, Professor Shaun Jackson presented his work on ‘Proinflammatory Function of Dying Platelets’.

Ischemic injury to the gut is particularly common in critical illness caused by pathological conditions such as severe sepsis, trauma and transplant rejection. Persisted gut ischemia can lead to the development of systemic inflammation and multiorgan failure. Lung injury is one of the earliest manifestations of this, with respiratory failure a common cause of death in critically ill patients.

“We’ve identified a distinct clotting mechanism that is triggered by the ischaemic conditions that develop in the gut of these critically ill patients,” says Prof Jackson. “Inflammatory changes occurring in the gut produce clots that in turn produce damage in other organs, in particular the lung.”

The mechanism, discovered by Prof Jackson and the Thrombosis Group, involves a distinct process whereby white blood cells form large macro-aggregates, triggered by dying platelets.

“This is exciting because we now have a new handle on how clotting occurs in these instances, which could relate to new methods of preventing or treating these clots,” Prof Jackson says.

White cell aggregate held together by dying platelet remnants that act like glue

The ISTH Congress promotes important scientific discourse and advancement, with thousands of the world’s leading experts on thrombosis, haemostasis and vascular biology coming together to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.

Previous
Next

Related news

Meet the team: Imala Alwis

I'm Imala Alwis and I am a senior research officer at the Heart Research Institute, working in the Thrombosis group. Heart disease has affected me personally. My dad was in his mid fifties when he had triple bypass surgery. He led a very healthy lifestyle and he was only diagnosed during a routine medical check up.

Read more

HRI researchers mentor talented students from New Zealand

HRI has welcomed eight talented researchers from New Zealand to take part in a summer scholarship at the HRI. Launched in December 2016, the 8-week scholarship provided high-achieving and promising Kiwi students the opportunity to work on a medical research project directly related to cardiovascular disease, expand on their skills and knowledge and be mentored in a world-class research institute. 

Read more

HRI takes home top award at annual scientific meeting

Dr Siân Cartland, from HRI's Vascular Complications Group, has been awarded the AVBS Young Investigator/Early Career Researcher (ECR) Best Oral Presentation at the Joint Annual Scientific Meeting in Hobart. The Annual Scientific Meeting of the Australian Vascular Biology Society (AVBS) was held as a joint meeting with the Australian Atherosclerosis Society (AAS) and High Blood Pressure Research Council of Australia (HBPRCA) from 7-10 December 2016.

Read more